Literature DB >> 27411906

Insight into rheumatological cause and effect through the use of Mendelian randomization.

Philip C Robinson1,2, Hyon K Choi3, Ron Do4, Tony R Merriman5.   

Abstract

Establishing causality of risk factors is important to determine the pathogenetic mechanisms underlying rheumatic diseases, and can facilitate the design of interventions to improve care for affected patients. The presence of unmeasured confounders, as well as reverse causation, is a challenge to the assignment of causality in observational studies. Alleles for genetic variants are randomly inherited at meiosis. Mendelian randomization analysis uses these genetic variants to test whether a particular risk factor is causal for a disease outcome. In this Review of the Mendelian randomization technique, we discuss published results and potential applications in rheumatology, as well as the general clinical utility and limitations of the approach.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27411906     DOI: 10.1038/nrrheum.2016.102

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  114 in total

Review 1.  Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.

Authors:  Earl S Ford; S Jay Smith; Donna F Stroup; Karen K Steinberg; Patricia W Mueller; Stephen B Thacker
Journal:  Int J Epidemiol       Date:  2002-02       Impact factor: 7.196

Review 2.  Mendelian randomization studies: a review of the approaches used and the quality of reporting.

Authors:  Anna G C Boef; Olaf M Dekkers; Saskia le Cessie
Journal:  Int J Epidemiol       Date:  2015-05-06       Impact factor: 7.196

3.  Vitamin D3 and the risk of CVD in overweight and obese women: a randomised controlled trial.

Authors:  Amin Salehpour; Farzad Shidfar; Farhad Hosseinpanah; Mohammadreza Vafa; Maryam Razaghi; Anahita Hoshiarrad; Mahmoodreza Gohari
Journal:  Br J Nutr       Date:  2012-02-09       Impact factor: 3.718

4.  Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study.

Authors:  Jeppe Frederiksen; Klaus Juul; Peer Grande; Gorm B Jensen; Torben V Schroeder; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Journal:  Blood       Date:  2004-06-29       Impact factor: 22.113

5.  Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers.

Authors:  Armin Zittermann; Sabine Frisch; Heiner K Berthold; Christian Götting; Joachim Kuhn; Knut Kleesiek; Peter Stehle; Heinrich Koertke; Reiner Koerfer
Journal:  Am J Clin Nutr       Date:  2009-03-25       Impact factor: 7.045

6.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.

Authors:  E W Campion; R J Glynn; L O DeLabry
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

Review 7.  The effects of high phosphorus intake on calcium homeostasis.

Authors:  M S Calvo
Journal:  Adv Nutr Res       Date:  1994

8.  Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study.

Authors:  Daniela Di Giuseppe; Lars Alfredsson; Matteo Bottai; Johan Askling; Alicja Wolk
Journal:  BMJ       Date:  2012-07-10

9.  Reduced glomerular function and prevalence of gout: NHANES 2009-10.

Authors:  Eswar Krishnan
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

10.  Prenatal alcohol exposure and offspring cognition and school performance. A 'Mendelian randomization' natural experiment.

Authors:  Luisa Zuccolo; Sarah J Lewis; George Davey Smith; Kapil Sayal; Elizabeth S Draper; Robert Fraser; Margaret Barrow; Rosa Alati; Sue Ring; John Macleod; Jean Golding; Jon Heron; Ron Gray
Journal:  Int J Epidemiol       Date:  2013-09-24       Impact factor: 7.196

View more
  16 in total

1.  Insight into rheumatological cause and effect through the use of Mendelian randomization.

Authors:  Philip C Robinson; Hyon K Choi; Ron Do; Tony R Merriman
Journal:  Nat Rev Rheumatol       Date:  2017-02-22       Impact factor: 20.543

2.  Evaluating marginal genetic correlation of associated loci for complex diseases and traits between European and East Asian populations.

Authors:  Haojie Lu; Ting Wang; Jinhui Zhang; Shuo Zhang; Shuiping Huang; Ping Zeng
Journal:  Hum Genet       Date:  2021-06-06       Impact factor: 4.132

Review 3.  Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation.

Authors:  Richard J Johnson; George L Bakris; Claudio Borghi; Michel B Chonchol; David Feldman; Miguel A Lanaspa; Tony R Merriman; Orson W Moe; David B Mount; Laura Gabriella Sanchez Lozada; Eli Stahl; Daniel E Weiner; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2018-02-27       Impact factor: 8.860

Review 4.  The Interaction Between Dietary Fructose and Gut Microbiota in Hyperuricemia and Gout.

Authors:  Xin-Yu Fang; Liang-Wei Qi; Hai-Feng Chen; Peng Gao; Qin Zhang; Rui-Xue Leng; Yin-Guang Fan; Bao-Zhu Li; Hai-Feng Pan; Dong-Qing Ye
Journal:  Front Nutr       Date:  2022-06-22

5.  Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand.

Authors:  Mohanraj Krishnan; Tanya J Major; Ruth K Topless; Ofa Dewes; Lennex Yu; John M D Thompson; Lesley McCowan; Janak de Zoysa; Lisa K Stamp; Nicola Dalbeth; Jennie Harré Hindmarsh; Nuku Rapana; Ranjan Deka; Winston W H Eng; Daniel E Weeks; Ryan L Minster; Stephen T McGarvey; Satupa'itea Viali; Take Naseri; Muagututi'a Sefuiva Reupena; Phillip Wilcox; David Grattan; Peter R Shepherd; Andrew N Shelling; Rinki Murphy; Tony R Merriman
Journal:  Diabetologia       Date:  2018-05-02       Impact factor: 10.122

6.  Genetic correlations between traits associated with hyperuricemia, gout, and comorbidities.

Authors:  Richard J Reynolds; M Ryan Irvin; S Louis Bridges; Hwasoon Kim; Tony R Merriman; Donna K Arnett; Jasvinder A Singh; Nicholas A Sumpter; Alexa S Lupi; Ana I Vazquez
Journal:  Eur J Hum Genet       Date:  2021-02-26       Impact factor: 5.351

7.  Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study.

Authors:  Johannes Nossent; Warren Raymond; Mark Divitini; Matthew Knuiman
Journal:  BMC Cardiovasc Disord       Date:  2016-12-15       Impact factor: 2.298

Review 8.  ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches.

Authors:  M C Cleophas; L A Joosten; L K Stamp; N Dalbeth; O M Woodward; Tony R Merriman
Journal:  Pharmgenomics Pers Med       Date:  2017-04-20

9.  A Bayesian approach to Mendelian randomization with multiple pleiotropic variants.

Authors:  Carlo Berzuini; Hui Guo; Stephen Burgess; Luisa Bernardinelli
Journal:  Biostatistics       Date:  2020-01-01       Impact factor: 5.899

Review 10.  Formalising recall by genotype as an efficient approach to detailed phenotyping and causal inference.

Authors:  Laura J Corbin; Vanessa Y Tan; David A Hughes; Kaitlin H Wade; Dirk S Paul; Katherine E Tansey; Frances Butcher; Frank Dudbridge; Joanna M Howson; Momodou W Jallow; Catherine John; Nathalie Kingston; Cecilia M Lindgren; Michael O'Donavan; Stephen O'Rahilly; Michael J Owen; Colin N A Palmer; Ewan R Pearson; Robert A Scott; David A van Heel; John Whittaker; Tim Frayling; Martin D Tobin; Louise V Wain; George Davey Smith; David M Evans; Fredrik Karpe; Mark I McCarthy; John Danesh; Paul W Franks; Nicholas J Timpson
Journal:  Nat Commun       Date:  2018-02-19       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.